Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc.
EpicentRx, Inc.
Cornerstone Pharmaceuticals
Janssen Research & Development, LLC
RTOG Foundation, Inc.
M.D. Anderson Cancer Center
Tufts Medical Center
University of Florida
Sun Yat-sen University
City of Hope Medical Center
French Innovative Leukemia Organisation
SWOG Cancer Research Network
Children's Hospital of Philadelphia
SWOG Cancer Research Network
SWOG Cancer Research Network
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris